Heart Failure News and Research

RSS

Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.

Poster summarizing clinical trial data regarding SB-743921 presented by Cytokinetics

Cytokinetics, Incorporated announced today that a poster summarizing clinical trial data regarding SB-743921 was presented at the 2009 American Society of Hematology (ASH) Annual Meeting and Exposition held December 5-8, 2009 at the Ernest N. Morial Convention Center in New Orleans, Louisiana.

7 Dec 2009

VELCADE based regimens are cost-effective for payers and patients, finds study

Millennium: The Takeda Oncology Company today announced that two studies presented at the 51st American Society of Hematology (ASH) Annual Meeting found that VELCADE based regimens are more cost-effective for payers and reduced out-of-pocket costs for patients than other commonly used multiple myeloma treatments.

7 Dec 2009

Unique project to address key healthcare reform issue to be launched

Groundbreaking ceremonies on December 15 will mark the launch of a unique project that exemplifies how new technologies are being used to address a key healthcare reform issue: the multi-billion dollar cost of repeatedly hospitalizing patients with chronic conditions such as diabetes, high blood pressure, heart failure, asthma and lung disease.

5 Dec 2009

FDA approves Santarus’ NDA for immediate-release prescription tablet product

Santarus, Inc., a specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s New Drug Application (NDA) for immediate-release omeprazole/sodium bicarbonate/ magnesium hydroxide tablets in 40 mg and 20 mg dosage strengths of omeprazole.

5 Dec 2009

Results from Phase III pivotal study of FIRMAGON presented

Drs. Neal Shore and E. David Crawford presented results for prostate-specific antigen (PSA) recurrence from the additional analysis of secondary end points of biochemical recurrence rate in a Phase III pivotal study of FIRMAGON® (monthly degarelix for injection) or monthly leuprolide in prostate cancer patients during the first year of treatment.

4 Dec 2009

Pfizer to present study findings from its expanded breast cancer portfolio

Pfizer Oncology announced today that it will be presenting study findings evaluating several compounds including those from its newly expanded breast cancer portfolio following the recent acquisition of Wyeth, focusing on the needs of multiple breast cancer patient populations at the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) being held December 9 – 13.

4 Dec 2009

Guardsman Scientific emerges as winner of New England Venture Summit Top Innovator award

Guardsman Scientific is pleased to announce that it has been selected as a winner of the annual New England Venture Summit Top Innovator award by youngStartup Ventures.

4 Dec 2009

Mitral valve repair by experienced surgeons improves the survival rate of patients

Superior surgical techniques used in centres such as the University of Ottawa Heart Institute (UOHI) to fix a faulty heart valve flap, eliminate severe blood leakage and other serious cardiac conditions are highlighted as an expert guide to physicians and featured today in one of medicine's most prestigious journals.

4 Dec 2009

Data from recent clinical trial for Caldolor Injection to be presented

Cumberland Pharmaceuticals Inc. announced today that data from a recent clinical trial for Caldolor® (ibuprofen) Injection, an intravenous treatment for pain and fever, will be presented at the 44th American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting in Las Vegas, Nevada, in December.

4 Dec 2009

Usefulness of heart rate variability as a diagnostic for identifying dysfunction established

According to Dr. Daniel Weiss, a recent study of heart rate autonomic markers, and cardiac mortality published in the November issue of Heart Rhythm provides additional support for the usefulness of heart rate variability as a diagnostic for identifying dysfunction (neuropathy in diabetics and others) and cardiovascular mortality, including fatal arrhythmia or sudden cardiac death.

4 Dec 2009

Sulphonylureas, an antidiabetic drug, carries greater risk of heart failure and death compared to metformin

Research: Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: Retrospective cohort study using UK general practice research database

4 Dec 2009

Hyperion Therapeutics commences enrollment in its HPN-100 episodic hepatic encephalopathy trial

Hyperion Therapeutics, Inc. today announced that the first patient has been enrolled in its phase II clinical trial of investigational compound HPN-100 (glycerol phenylbutyrate).

3 Dec 2009

Care Support of America's outpatient palliative care coordination model improves the quality of life for seniors

Care Support of America's model of outpatient palliative care coordination, Advanced Illness Coordinated Care (AICC), has been shown to reduce hospitalizations in the last years of life as well as improve the quality of life for seniors and their family caregivers without increasing mortality. These are the principal findings of a new study published in American Journal of Managed Care (November 2009).

3 Dec 2009

More than 80 abstracts highlighting Bristol-Myers Squibb's oncology compound to be presented

Bristol-Myers Squibb Company today announced that more than 80 abstracts highlighting compounds from the company’s oncology portfolio will be presented at the 51st Annual Meeting of the American Society of Hematology (ASH) to be held December 5-8 in New Orleans.

3 Dec 2009

SJH and Pharos Innovations team up to enhance care and reduce healthcare costs

According to Stephen F. Jencks, MD, MPH, in a recent New England Journal of Medicine article, America's healthcare crisis is fueled by unnecessary and costly hospitalizations, including re-admissions -- 90% of which are unplanned and at a price-tag of $17.4 billion. To enhance care and combat readmissions, South Jersey Healthcare (SJH), a leading regional healthcare provider in southern New Jersey, has entered a partnership with Pharos Innovations that aims to reduce healthcare costs while improving quality of life for patients.

3 Dec 2009

MSC's Quality Initiative Programs to be highlighted at the 2009 IHI National Forum

Medical Simulation Corporation (MSC) will highlight its full menu of Quality Initiative Programs at the 2009 IHI National Forum, December 7-9, 2009, in Orlando, Florida. MSC is the first simulation company to introduce simulation-based education programs that help healthcare providers bridge the gap between measurement and achievement of publicly reported patient safety and quality initiatives.

2 Dec 2009

Sorin Group includes the first patient in its Clepsydra clinical trial

Sorin Group announced today the first inclusion of a patient in the Clepsydra clinical trial. The study will investigate the sensitivity to changes in heart failure status of PhD™, a unique diagnostic feature using the dual sensor technology of minute ventilation and accelerometer to monitor patient’s breathing and activity levels every day.

2 Dec 2009

New data demonstrating the strength of Novartis' hematology portfolio to be presented

Novartis announced today that new data, including a late-breaking presentation on Tasigna® (nilotinib) 200 mg capsules in a form of chronic myeloid leukemia, demonstrate the strength of the company's hematology portfolio in advancing the care of patients.

2 Dec 2009

New data on pixantrone Phase III trial in non-Hodgkin's lymphoma to be presented

Cell Therapeutics, Inc. (CTI) announced today that Ruth Pettengell, M.D. of St. George's Hospital, University of London, the lead investigator for the PIX 301 EXTEND trial will present new data on the pixantrone phase III trial in relapsed/refractory aggressive non-Hodgkin's lymphoma (NHL) at the 51st Annual Meeting of the American Society of Hematology on Saturday, December 5, 2009 in New Orleans, Louisiana.

2 Dec 2009

Study identifies genetic link between vitamin D and heart disease

Previous studies have shown a link between low vitamin D status and heart disease. Now a new study shows that patients with high blood pressure who possess a gene variant that affects an enzyme critical to normal vitamin D activation are twice as likely as those without the variant to have congestive heart failure.

2 Dec 2009

Heart Failure News and Research

Further Reading

Poster summarizing clinical trial data regarding SB-743921 presented by Cytokinetics

VELCADE based regimens are cost-effective for payers and patients, finds study

Unique project to address key healthcare reform issue to be launched

FDA approves Santarus’ NDA for immediate-release prescription tablet product

Results from Phase III pivotal study of FIRMAGON presented

Pfizer to present study findings from its expanded breast cancer portfolio

Guardsman Scientific emerges as winner of New England Venture Summit Top Innovator award

Mitral valve repair by experienced surgeons improves the survival rate of patients

Data from recent clinical trial for Caldolor Injection to be presented

Usefulness of heart rate variability as a diagnostic for identifying dysfunction established

Sulphonylureas, an antidiabetic drug, carries greater risk of heart failure and death compared to metformin

Hyperion Therapeutics commences enrollment in its HPN-100 episodic hepatic encephalopathy trial

Care Support of America's outpatient palliative care coordination model improves the quality of life for seniors

More than 80 abstracts highlighting Bristol-Myers Squibb's oncology compound to be presented

SJH and Pharos Innovations team up to enhance care and reduce healthcare costs

MSC's Quality Initiative Programs to be highlighted at the 2009 IHI National Forum

Sorin Group includes the first patient in its Clepsydra clinical trial

New data demonstrating the strength of Novartis' hematology portfolio to be presented

New data on pixantrone Phase III trial in non-Hodgkin's lymphoma to be presented

Study identifies genetic link between vitamin D and heart disease

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News